West Pharmaceutical Services, Inc. (NYSE:WST) Raises Dividend to $0.26 Per Share

West Pharmaceutical Services, Inc. (NYSE:WST) declared a quarterly dividend on Monday, October 19th. Shareholders of record on Wednesday, November 11th will be paid a dividend of $0.26 per share by the medical instruments supplier on Wednesday, November 18th. This represents a $1.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Tuesday, November 10th. This is a 18.2% increase from West Pharmaceutical Services’s previous quarterly dividend of $0.22.

West Pharmaceutical Services has increased its dividend by an average of 0.1% per year over the last three years. West Pharmaceutical Services has a dividend payout ratio of 12.4% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect West Pharmaceutical Services to earn $9.90 per share next year, which means the company should continue to be able to cover its $0.88 annual dividend with an expected future payout ratio of 8.9%.

West Pharmaceutical Services Stock Up 0.6%

Shares of West Pharmaceutical Services stock opened at $386.05 on Tuesday. The company has a current ratio of 2.82, a quick ratio of 2.12 and a debt-to-equity ratio of 0.07. West Pharmaceutical Services has a 12-month low of $223.83 and a 12-month high of $387.01. The company has a market cap of $27.17 billion, a P/E ratio of 49.32, a PEG ratio of 2.69 and a beta of 1.13. The company’s fifty day simple moving average is $358.63 and its two-hundred day simple moving average is $333.88.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 23rd. The medical instruments supplier reported $2.37 EPS for the quarter, topping the consensus estimate of $2.08 by $0.29. The firm had revenue of $872.30 million during the quarter, compared to analysts’ expectations of $839.98 million. West Pharmaceutical Services had a net margin of 16.98% and a return on equity of 20.11%. The company’s quarterly revenue was up 13.8% compared to the same quarter last year. During the same period last year, the company posted $1.84 EPS. West Pharmaceutical Services has set its Q3 2026 guidance at 2.140-2.240 EPS and its FY 2026 guidance at 8.850-9.050 EPS. Research analysts anticipate that West Pharmaceutical Services will post 8.93 EPS for the current year.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc develops and manufactures components and delivery systems used in the administration and packaging of injectable medicines and other healthcare products. Its offerings include elastomer closures, seals, syringe components, drug-delivery systems, and other specialized packaging components designed to support the safety, quality, and performance of pharmaceutical products.

The company also provides contract-manufacturing services for pharmaceutical, biotechnology, and medical-device customers.